Densiron intraocular tamponade: a case series.
OBJECTIVE
To report on the use of Densiron (heavy silicone oil), a new endotamponade agent with proposed benefits in complex retinal detachments involving inferior proliferative vitreoretinopathy.


METHODS
Retrospective case note review.


RESULTS
Ten cases (10 eyes) in which Densiron was used in eyes which had failed initial retinal detachment surgery. The overall success rate of long-term total reattachment was 70%. Mean preoperative visual acuity was logMAR 2.03 (SD 0.406), which improved to a mean postoperative visual acuity of logMAR 1.00 (SD 0.571) (P = 0.001).


CONCLUSIONS
Densiron was well tolerated with few side-effects and appears to be a useful agent in patients with inferior proliferative vitreoretinopathy.
Lim
Beng Liam
BL
The Eye Hospital, Launceston, Tasmania, Australia.
Vote
Brendan
B
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D009877:Endophthalmitis / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000209:etiology; D015814:Ocular Hypotension / Q000209:etiology; D011184:Postoperative Period; D012008:Recurrence; D012163:Retinal Detachment / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D012189:Retrospective Studies; D012827:Silicone Oils / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014792:Visual Acuity; D014821:Vitrectomy / Q000009:adverse effects; D018630:Vitreoretinopathy, Proliferative / Q000209:etiology* / Q000503:physiopathology
D012827:Silicone Oils; C515608:densiron